Literature DB >> 9570641

Portacaval anastomosis results in more widespread alterations of cerebral metabolism in old versus young adult rats: implications for post-shunt encephalopathy.

R M Audet1, R F Butterworth.   

Abstract

Treatment of portal hypertension by portal decompressive surgery or transjugular intrahepatic portosystemic stent shunt (TIPS) results in new or worsening episodes of portal-systemic encephalopathy, particularly in older patients. As part of a series of studies to elucidate the pathophysiologic mechanisms responsible for the age-related increased portal-systemic encephalopathy following shunt surgery, local cerebral glucose utilization, a measure of regional brain functional activity, was assessed using the 14C-2-deoxyglucose autoradiographic technique in 2 month-old (young adult) and 24 month-old (old adult) rats following end-to-side portacaval anastomosis. Cerebral glucose utilization was decreased by 22% (p<0.05) in frontal cortex of 2 month-old rats following portacaval anastomosis. More widespread alterations of glucose utilization, involving frontal and frontoparietal cortices, as well as thalamic structures were observed in the brains of 24 month-old rats following portacaval anastomosis despite blood ammonia concentrations of a comparable magnitude. Decreased cerebral glucose utilization in frontal and frontoparietal cortex of old adult rats following portacaval anastomosis probably results from decreased cerebral energy requirements as a consequence of neurotransmitter-related dysfunction. The greater susceptibility of aging brain to the deleterious effects of portacaval anastomosis is consistent with the higher incidence of encephalopathy in older cirrhotic patients following portacaval anastomosis or TIPS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9570641     DOI: 10.1023/a:1020683013238

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  37 in total

Review 1.  Synaptic transmission in ammonia intoxication.

Authors:  W Raabe
Journal:  Neurochem Pathol       Date:  1987 Feb-Apr

2.  [Enzymatic determination of glucose and fructose simultaneously].

Authors:  F H SCHMIDT
Journal:  Klin Wochenschr       Date:  1961-12-01

3.  Portacaval shunt in the rat.

Authors:  S H LEE; B FISHER
Journal:  Surgery       Date:  1961-10       Impact factor: 3.982

4.  Cerebral blood flow and cerebral metabolic rate for oxygen in rats with porta-caval anastomosis.

Authors:  B Eklöf; T Holmin; H Jóhannsson; B K Siesjö
Journal:  Acta Physiol Scand       Date:  1974-02

5.  Regional cerebral glucose utilization in rats with portacaval anastomosis.

Authors:  A M Mans; J F Biebuyck; D W Davis; R M Bryan; R A Hawkins
Journal:  J Neurochem       Date:  1983-04       Impact factor: 5.372

6.  Effect of ammonia on brain serotonin metabolism in relation to function in the portacaval shunted rat.

Authors:  M Bergeron; M S Swain; T A Reader; L Grondin; R F Butterworth
Journal:  J Neurochem       Date:  1990-07       Impact factor: 5.372

7.  Selective alterations of extracellular brain amino acids in relation to function in experimental portal-systemic encephalopathy: results of an in vivo microdialysis study.

Authors:  V L Rao; R M Audet; R F Butterworth
Journal:  J Neurochem       Date:  1995-09       Impact factor: 5.372

8.  Portacaval anastomosis induces region-selective alterations of the endogenous opioid system in the rat brain.

Authors:  J P de Waele; R M Audet; D K Leong; R F Butterworth
Journal:  Hepatology       Date:  1996-10       Impact factor: 17.425

9.  Positron-emission tomographic localization of abnormalities of brain metabolism in patients with minimal hepatic encephalopathy.

Authors:  A H Lockwood; B W Murphy; K Z Donnelly; T C Mahl; S Perini
Journal:  Hepatology       Date:  1993-11       Impact factor: 17.425

10.  Portosystemic encephalopathy after transjugular intrahepatic portosystemic shunt: results of a prospective controlled study.

Authors:  A J Sanyal; A M Freedman; M L Shiffman; P P Purdum; V A Luketic; A K Cheatham
Journal:  Hepatology       Date:  1994-07       Impact factor: 17.425

View more
  5 in total

Review 1.  Alterations of neurotransmitter-related gene expression in human and experimental portal-systemic encephalopathy.

Authors:  R F Butterworth
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

Review 2.  Neurotransmitter dysfunction in hepatic encephalopathy: new approaches and new findings.

Authors:  R F Butterworth
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

Review 3.  Neuronal nitric oxide synthase and Hepatic Encephalopathy.

Authors:  V L Rao; R F Butterworth
Journal:  Metab Brain Dis       Date:  1998-09       Impact factor: 3.584

Review 4.  Cerebral energy metabolism in hepatic encephalopathy and hyperammonemia.

Authors:  K V Rao; M D Norenberg
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

5.  Selective alterations of brain dopamine D(2) receptor binding in cirrhotic patients: results of a (11)C-N-methylspiperone PET study.

Authors:  Yuki Watanabe; Akinobu Kato; Kei Sawara; Roger F Butterworth; Toshiaki Sasaki; Kazunori Terasaki; Koichiro Sera; Kazuyuki Suzuki
Journal:  Metab Brain Dis       Date:  2008-08-07       Impact factor: 3.584

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.